Scarica l'app Stockscreener
4.86
3.40%
0.16
Dopo l'orario di chiusura:
4.80
-0.06
-1.23%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WVE Giù?
Forum
Previsione
Wave Life Sciences Ltd Borsa (WVE) Ultime notizie
Wave Life Sciences stock holds steady ahead of Cantor healthcare conference appearance - AD HOC NEWS
Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference - Yahoo Finance
Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Wave Life Sciences stock trades quietly as investors focus on recent clinical progress - AD HOC NEWS
WAVE Life Sciences (NASDAQ:WVE) Downgraded by Zacks Research to "Hold" - MarketBeat
Wave Life Sciences (WVE) Files To Deregister Its Ordinary Shares - simplywall.st
What Went Wrong For WVE? The Obesity Drug Trial Data That Spooked Investors - Stocktwits
WVE Stock Edges Up After Positive Early Data For Rare Disease Drug - Stocktwits
Wave Life Sciences targets fat loss without sacrificing muscle - Longevity.Technology
Insiders Sold Wave Life Sciences Prematurely At US$13.64 With Stock Trading Higher - Moomoo
Wave Life Sciences (WVE) Pulls Back 5.2% to $5.13 as Support Holds at $4.87Thematic ETF Flow - vinanet.vn
Wave Life Sciences Ltd. SEC Filing (Aug 17, 2026) - Stock Titan
Precision Trading with Wave Life Sciences Ltd. (WVE) Risk Zones - Stock Traders Daily
Wave Life Sciences, Inc.: Top Mutual Funds Holders | WVE | US94352A1043 - marketscreener.com
Wave Life Sciences, Inc.: Target Price Consensus and Analysts Recommendations | WVE | US94352A1043 - marketscreener.com
Wave Life Sciences, Inc.: Performance & Quotes, WVE Stock Price on Nasdaq Exchange - marketscreener.com
Wave Life Sciences, Inc.: Fundamental Analysis and Financial Ratings | WVE | US94352A1043 - marketscreener.com
Wave Life Sciences, Inc.: Financial Data Forecasts Estimates and Expectations | WVE | US94352A1043 - marketscreener.com
Wave Life Sciences, Inc. Stock (WVE)Quote Nasdaq - marketscreener.com
Q1 2025 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus
WAVE Life Sciences Ltd at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus
Q2 2026 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus
Wave Life Sciences Ltd.: Revenue and Earnings Analysts Forecasts Revisions | WVE | US94352A1043 - marketscreener.com
Wave Life Sciences (WVE) Director Adrian Rawcliffe Sells 12,700 Shares, Reducing Stake to Zero - GuruFocus
WAVE Life Sciences (NASDAQ:WVE) Director Adrian Rawcliffe Sells 12,700 Shares - MarketBeat
Ken Takanashi Sells 3,864 Shares of WAVE Life Sciences (NASDAQ:WVE) Stock - MarketBeat
Wave Life Sciences (WVE) director’s 3,864-share tax sale under 10b5-1 plan - Stock Titan
Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover - Yahoo Finance
Wave Life Sciences (WVE) Stock Looks Cheap After A 68% Fall But Expensive On Sales - simplywall.st
Wave Life Sciences Ltd. SEC Filing (Aug 12, 2026) - Stock Titan
Wave Life Sciences at canaccord growth conference: obesity and RNA bets - Investing.com Canada
BofA Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $17 - Moomoo
WAVE Life Sciences (NASDAQ:WVE) Hits New 52-Week LowHere's What Happened - MarketBeat
Wave Life Sciences: An Fairly Valued RNA Opportunity - Seeking Alpha
Wave Life Sciences stock hits 52-week low at $5.01 By Investing.com - Investing.com Australia
RA Capital group discloses 16.8% Wave Life Sciences (WVE) ownership after redomiciliation - Stock Titan
Wave Life Sciences Ltd. SEC Filing (Aug 11, 2026) - Stock Titan
Wave Life Sciences stock hits 52-week low at $5.01 - Investing.com
Wave Life Sciences at Bank of America SMID Cap Virtual Conference: pipeline bets - Investing.com Nigeria
WAVE Life Sciences (NASDAQ:WVE) Stock Price Down 6.8%Should You Sell? - MarketBeat
Q2 2025 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus
Wave Life Sciences Inc (FRA:0VS) Stock Earnings Transcripts - GuruFocus
Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring A 214% Upside In Biotech's Future - DirectorsTalk Interviews
WAVE Life Sciences: Target Price Consensus and Analysts Recommendations | WVE | US94352A1043 - marketscreener.com
WAVE Life Sciences: Fundamental Analysis and Financial Ratings | WVE | US94352A1043 - marketscreener.com
WAVE Life Sciences: Financial Data Forecasts Estimates and Expectations | WVE | US94352A1043 - marketscreener.com
Analysts Just Made A Major Revision To Their Wave Life Sciences Ltd. (NASDAQ:WVE) Revenue Forecasts - webull.com
WAVE Life Sciences (NASDAQ:WVE) Shares Gap UpHere's Why - MarketBeat
Wave Life Sciences Completes Redomiciliation to Delaware - marketscreener.com
Wave Life Sciences completes redomiciliation to Delaware By Investing.com - Investing.com Australia
Wave Life Sciences Completes Redomiciliation From Singapore to Delaware - citybiz
Wave Life Sciences completes redomiciliation to Delaware - Investing.com
Wave Life Sciences Announces Completion of Redomiciliation to Delaware Corporation - Quiver Quantitative
Wave Life Sciences Announces Completion of Redomiciliation to Delaware - The Manila Times
Wave Life Sciences Announces Completion of Redomiciliation to Delaware | Associated Press | syndication news - Enidnews.com
Wave Life Sciences Keeps WVE Ticker After Delaware Parent Move - Stock Titan
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):